The Emergence of Omicron: A variant of concern - By Dr. Ashwini

Speciality: Infectious diseases


Speaker:

Dr. Ashwini M Shetty | Infedis health

Description:

A warm welcome to all the medical professionals in this interesting session on The Emergence of Omicron: A Variant of Concern - By Dr. Ashwini.

Dr. Ashwini discusses the emergence of Omicron, a variant of concern of the SARS-CoV-2 virus, which was first identified in South Africa in late 2021. Omicron quickly gained global attention due to its unprecedented number of mutations in the spike protein, raising concerns about increased transmissibility and potential resistance to existing vaccines and treatments.

Omicron's rapid spread has been attributed to its ability to evade immunity from previous infections and vaccinations more effectively than earlier variants. Dr. Ashwini highlights that, despite its higher transmissibility, preliminary data suggested that Omicron might cause less severe disease compared to the Delta variant. However, the sheer volume of cases posed significant challenges to healthcare systems worldwide, leading to increased hospitalizations and strain on medical resources.

To combat Omicron, Dr. Ashwini emphasizes the importance of booster vaccination campaigns, which have shown to enhance protection against this variant. Additionally, ongoing research and adaptation of COVID-19 treatments and preventive measures are crucial in addressing the evolving threat posed by Omicron and future variants. Public health strategies, including widespread testing, genomic surveillance, and reinforcing public health measures, remain essential in mitigating the impact of Omicron.

Therefore, get an overall knowledge of Th

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients face high out-of-pocket costs after incident cancer diagnosis

2.

In a study, immune detection of oral cancers is linked to obesity.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Common intracellular toxin could help fight leukemia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot